Prevalence and Clinical Significance of Serum Sodium Variability in Patients with Acute-on-chronic Liver Diseases: a Prospective Multicenter Study in China
Mei Xue,Chinese Ministry of Health (Shanghai Jiao Tong University),Deng Guohong,Wang Xianbo,Zheng Xin,Huang Yan,Chen Jinjun,Meng Zhongji,Gao Yanhang,Liu Feng,Lu Xiaobo,National Clinical Research Center of Infectious Disease,Zheng Yubao,Yan Huadong,Zhang Weituo,Xiang Xiaomei,Zhou Yi,Sun Shuning,Hou Yixin,Zhang Qun,Xiong Yan,Zou Congcong,Chen Jun,Huang Zebing,Li Beiling,Jiang Xiuhua,Zhong Guotao,Wang Haiyu,Chen Yuanyuan,Luo Sen,Gao Na,Liu Chunyan,Li Jing,Li Tao,Zheng Rongjiong,Zhou Xinyi,Yuan Wei,Qian Zhiping
DOI: https://doi.org/10.1007/s12072-021-10282-8
IF: 9.029
2022-01-01
Hepatology International
Abstract:No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. We prospectively collected the data of 3970 patients with AoCLD from the CATCH-LIFE cohort in China. The prevalence of different Na levels (≤ 120; 120–135; 135–145; > 145) and their relationship with 90-day prognosis were analyzed. For hyponatremic patients, we measured Na levels on days 4 and 7 and compared their characteristics, based on whether hyponatremia was corrected. A total of 3880 patients were involved; 712 of those developed adverse outcomes within 90 days. There were 80 (2.06%) hypernatremic, 28 (0.72%) severe hyponatremic, and 813 (20.95%) mild hyponatremic patients at admission. After adjusting for all confounding factors, the risk of 90-day adverse outcomes decreased by 5% (odds ratio [OR] 0.95; 95% confidence interval [CI] 0.93–0.97; p < 0.001), 24% (OR 0.76; 95% CI 0.70–0.84; p < 0.001), and 42% (OR 0.58; 95% CI 0.49–0.70; p < 0.001) as Na level increased by 1, 5, and 10 mmol/L, respectively. Noncorrection of hyponatremia on days 4 and 7 was associated with 2.05-fold (hazard ratio [HR], 2.05; 95% CI, 1.50–2.79; p < 0.001) and 1.46-fold (HR 1.46; 95% CI 1.05–2.02; p = 0.028) higher risk of adverse outcomes. Hyponatremia was an independent risk factor for a poor 90-day prognosis in patients with AoCLD. Failure to correct hyponatremia in a week after admission was often associated with increased mortality. (ClinicalTrials.gov number: NCT02457637, NCT03641872). This study is registered at Shanghai www.clinicaltrials.org (NCT02457637 and NCT03641872).